Sharon Rossiter

941 total citations
21 papers, 761 citations indexed

About

Sharon Rossiter is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Sharon Rossiter has authored 21 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Organic Chemistry and 3 papers in Toxicology. Recurrent topics in Sharon Rossiter's work include Chemical Synthesis and Analysis (4 papers), Synthesis and Biological Evaluation (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Sharon Rossiter is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Synthesis and Biological Evaluation (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Sharon Rossiter collaborates with scholars based in United Kingdom, United States and Serbia. Sharon Rossiter's co-authors include Patrick Vallance, David L. Selwood, Keith Jones, James Leiper, P. J. Whitfield, Manasi Nandi, Mohammed Malaki, Caroline L. Smith, Jean‐Marie Péron and B.P. O'Hara and has published in prestigious journals such as Nature Medicine, Diabetes and Chemical Communications.

In The Last Decade

Sharon Rossiter

20 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon Rossiter United Kingdom 12 273 244 206 145 114 21 761
De Lin United States 14 204 0.7× 527 2.2× 133 0.6× 56 0.4× 106 0.9× 23 1.1k
Marie A. Holahan United States 22 121 0.4× 278 1.1× 173 0.8× 206 1.4× 58 0.5× 50 1.1k
Susumu Tsushima Japan 14 157 0.6× 523 2.1× 171 0.8× 96 0.7× 77 0.7× 30 1.0k
P. Dorigo Italy 16 222 0.8× 333 1.4× 239 1.2× 136 0.9× 54 0.5× 77 854
Glenda E. Bilder United States 15 144 0.5× 393 1.6× 204 1.0× 144 1.0× 36 0.3× 26 922
Hélène Jûteau Canada 13 188 0.7× 346 1.4× 654 3.2× 67 0.5× 126 1.1× 22 1.4k
John H. Kinner United States 4 102 0.4× 217 0.9× 80 0.4× 156 1.1× 198 1.7× 6 722
Jaroslaw W. Żmijewski United States 10 223 0.8× 410 1.7× 41 0.2× 51 0.4× 127 1.1× 12 770
John P. Umland United States 14 94 0.3× 509 2.1× 144 0.7× 55 0.4× 80 0.7× 17 1.2k
Seongwoo Hwang United States 15 104 0.4× 506 2.1× 372 1.8× 52 0.4× 267 2.3× 21 1.2k

Countries citing papers authored by Sharon Rossiter

Since Specialization
Citations

This map shows the geographic impact of Sharon Rossiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Rossiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Rossiter more than expected).

Fields of papers citing papers by Sharon Rossiter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Rossiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Rossiter. The network helps show where Sharon Rossiter may publish in the future.

Co-authorship network of co-authors of Sharon Rossiter

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Rossiter. A scholar is included among the top collaborators of Sharon Rossiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Rossiter. Sharon Rossiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ostovar, Mehrnoosh, M.L. Scott, Tomasz P. Radon, et al.. (2020). Discovery of novel small molecule inhibitors of S100P with in vitro anti-metastatic effects on pancreatic cancer cells. European Journal of Medicinal Chemistry. 203. 112621–112621. 26 indexed citations
4.
Rossiter, Sharon, et al.. (2018). In Silico Structural Evaluation of Short Cationic Antimicrobial Peptides. Pharmaceutics. 10(3). 72–72. 8 indexed citations
5.
Goyal, Madhu, et al.. (2014). A cellulose-based bioassay for the colorimetric detection of pathogen DNA. Analytical and Bioanalytical Chemistry. 406(30). 7887–7898. 13 indexed citations
6.
Leiper, James, Manasi Nandi, Belén Torondel, et al.. (2007). Disruption of methylarginine metabolism impairs vascular homeostasis. Nature Medicine. 13(2). 198–203. 320 indexed citations
7.
Hartzoulakis, Basil, Sharon Rossiter, B.P. O'Hara, et al.. (2007). Discovery of inhibitors of the pentein superfamily protein dimethylarginine dimethylaminohydrolase (DDAH), by virtual screening and hit analysis. Bioorganic & Medicinal Chemistry Letters. 17(14). 3953–3956. 22 indexed citations
8.
Rossiter, Sharon, Jean‐Marie Péron, P. J. Whitfield, & Keith Jones. (2005). Synthesis and anthelmintic properties of arylquinolines with activity against drug-resistant nematodes. Bioorganic & Medicinal Chemistry Letters. 15(21). 4806–4808. 86 indexed citations
9.
Vallance, Patrick, et al.. (2005). Inhibition of dimethylarginine dimethylaminohydrolase (DDAH) and arginine deiminase (ADI) by pentafluorophenyl (PFP) sulfonates. Chemical Communications. 5563–5563. 21 indexed citations
10.
Rossiter, Sharon, Caroline L. Smith, Mohammed Malaki, et al.. (2005). Selective Substrate-Based Inhibitors of Mammalian Dimethylarginine Dimethylaminohydrolase. Journal of Medicinal Chemistry. 48(14). 4670–4678. 50 indexed citations
11.
Dobbs, Adrian P. & Sharon Rossiter. (2005). Imines and Their N‐Substituted Derivatives: NH, NR, and N‐Haloimines. ChemInform. 36(27). 1 indexed citations
12.
Rossiter, Sharon, Basil Hartzoulakis, Grant Wishart, et al.. (2004). Copper (II)-Mediated Arylation with Aryl Boronic Acids for the N-Derivatization of Pyrazole Libraries. Journal of Combinatorial Chemistry. 6(3). 385–390. 10 indexed citations
13.
Jones, Keith, et al.. (2003). Demethylation of 2,4-dimethoxyquinolines: the synthesis of atanine. Organic & Biomolecular Chemistry. 1(24). 4380–4380. 26 indexed citations
14.
Rossiter, Sharon, Lisa K. Folkes, & Peter Wardman. (2002). Halogenated indole-3-acetic acids as oxidatively activated prodrugs with potential for targeted cancer therapy. Bioorganic & Medicinal Chemistry Letters. 12(18). 2523–2526. 37 indexed citations
15.
Folkes, Lisa K., Sharon Rossiter, & Peter Wardman. (2002). Reactivity toward Thiols and Cytotoxicity of 3-Methylene-2-oxindoles, Cytotoxins from Indole-3-acetic Acids, on Activation by Peroxidases. Chemical Research in Toxicology. 15(6). 877–882. 8 indexed citations
16.
Rossiter, Sharon. (2002). A convenient synthesis of 3-methyleneoxindoles: cytotoxic metabolites of indole-3-acetic acids. Tetrahedron Letters. 43(26). 4671–4673. 34 indexed citations
17.
Greco, Olga, Sharon Rossiter, Chryso Kanthou, et al.. (2001). Horseradish peroxidase-mediated gene therapy: choice of prodrugs in oxic and anoxic tumor conditions.. PubMed. 1(2). 151–60. 38 indexed citations
18.
Lindsay, R M, et al.. (1995). Nω-Nitro-L-Arginine Methyl Ester Reduces the Incidence of IDDM in BB/E Rats. Diabetes. 44(3). 365–368. 45 indexed citations
19.
Davies, Eleanor, Sharon Rossiter, C.R.W. Edwards, & Brent C. Williams. (1992). Serotoninergic stimulation of aldosterone secretion in vivo: Role of the hypothalamo-pituitary adrenal axis. The Journal of Steroid Biochemistry and Molecular Biology. 42(1). 29–36. 2 indexed citations
20.
Davies, Eleanor, Sharon Rossiter, C.R.W. Edwards, & Brent C. Williams. (1991). Serotoninergic stimulation of aldosterone secretion in the rat in vivo: role of the renin-angiotensin system. Journal of Endocrinology. 130(3). 347–355. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026